Guo MH - Search Results

1

Determination and validation of chikusetsusaponin IVa in rat plasma by UPLC-MS/MS and its application to pharmacokinetic study.

Wang Y, Liu SP, Guo MH, Wang Z. Wang Y, et al. Among authors: guo mh. Biomed Chromatogr. 2016 Sep;30(9):1423-9. doi: 10.1002/bmc.3700. Epub 2016 Mar 1. Biomed Chromatogr. 2016. PMID: 26864353

2

Quantification of hydroxyurea in human plasma by HPLC-MS/MS and its application to pharmacokinetics in patients with chronic myeloid leukaemia.

Hai X, Guo M, Gao C, Zhou J. Hai X, et al. J Pharm Biomed Anal. 2017 Apr 15;137:213-219. doi: 10.1016/j.jpba.2017.01.008. Epub 2017 Jan 10. J Pharm Biomed Anal. 2017. PMID: 28131939

3

HPLC-HG-AFS determination of arsenic species in acute promyelocytic leukemia (APL) plasma and blood cells.

Guo M, Wang W, Hai X, Zhou J. Guo M, et al. J Pharm Biomed Anal. 2017 Oct 25;145:356-363. doi: 10.1016/j.jpba.2017.07.001. Epub 2017 Jul 6. J Pharm Biomed Anal. 2017. PMID: 28711674

4

Evaluation of arsenic species in leukocytes and granulocytes of acute promyelocytic leukemia patients treated with arsenic trioxide.

Wang X, Qian Z, Li H, Chen H, Lin L, Guo M, Hai X. Wang X, et al. J Pharm Biomed Anal. 2021 Sep 5;203:114201. doi: 10.1016/j.jpba.2021.114201. Epub 2021 Jun 8. J Pharm Biomed Anal. 2021. PMID: 34130006

5

Speciation analysis of arsenic in urine samples from APL patients treated with single agent As₂O₃ by HPLC-HG-AFS.

Guo M, Li J, Fan S, Liu W, Wang B, Gao C, Zhou J, Hai X. Guo M, et al. J Pharm Biomed Anal. 2019 Jul 15;171:212-217. doi: 10.1016/j.jpba.2019.04.014. Epub 2019 Apr 8. J Pharm Biomed Anal. 2019. PMID: 31009876

6

Characteristics and clinical influence factors of arsenic species in plasma and their role of arsenic species as predictors for clinical efficacy in acute promyelocytic leukemia (APL) patients treated with arsenic trioxide.

Guo M, Zhou J, Fan S, Li L, Chen H, Lin L, Zhao Q, Wang X, Liu W, Wu Z, Hai X. Guo M, et al. Expert Rev Clin Pharmacol. 2021 Apr;14(4):503-512. doi: 10.1080/17512433.2021.1893940. Epub 2021 Mar 8. Expert Rev Clin Pharmacol. 2021. PMID: 33678104

7

Time course of arsenic species in red blood cells of acute promyelocytic leukemia (APL) patients treated with single agent arsenic trioxide.

Guo M, Wang B, Liu S, Wang W, Gao C, Hu S, Fan S, Hai X, Zhou J. Guo M, et al. Expert Rev Clin Pharmacol. 2019 Apr;12(4):371-378. doi: 10.1080/17512433.2019.1586532. Epub 2019 Mar 11. Expert Rev Clin Pharmacol. 2019. PMID: 30795697

8

Effect of renal impairment on arsenic accumulation, methylation capacity, and safety in acute promyelocytic leukemia (APL) patients treated with arsenic trioxide.

Zhao Q, Guo M, Hostetter TH, Chen H, Lin L, Hai X. Zhao Q, et al. Expert Rev Clin Pharmacol. 2021 Sep;14(9):1173-1182. doi: 10.1080/17512433.2021.1938549. Epub 2021 Jun 28. Expert Rev Clin Pharmacol. 2021. PMID: 34181499

9

Monomethylated arsenic was the Major methylated arsenic in Red blood cells of acute promyelocytic leukemia patients treated with arsenic trioxide.

Guo S, Wang X, Gao C, Wu Z, Chen H, Lin L, Guo M, Gao Y, Hai X. Guo S, et al. Toxicol Lett. 2021 Sep 1;347:78-85. doi: 10.1016/j.toxlet.2021.04.005. Epub 2021 Apr 15. Toxicol Lett. 2021. PMID: 33865921

10

Clinical pharmacokinetics and safety profile of single agent arsenic trioxide by continuous slow-rate infusion in patients with newly diagnosed acute promyelocytic leukemia.

Gao C, Hu S, Guo M, Hai X, Zhou J. Gao C, et al. Cancer Chemother Pharmacol. 2018 Aug;82(2):229-236. doi: 10.1007/s00280-018-3606-8. Epub 2018 May 29. Cancer Chemother Pharmacol. 2018. PMID: 29845392 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters